輸入代號或公司名稱後按 Enter
4123

晟德

-0.10 (-0.33%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
30.251,051成交張數22.74本益比1.33股價淨值比7.42%殖利率2026-09-11資料日期

毛利率、營業利益率、淨利率

單季;近十年

單季營收

億元

季度營收(億)營收年增毛利(億)毛利率營業利益(億)營業利益率淨利率
2026Q24.314.1%1.943.6%4.9112.5%-2417.9%
2026Q14.723.0%2.246.6%-0.2-4.1%421.8%
2025Q44.0-10.9%1.741.9%-4.2-106.2%1697.7%
2025Q33.6-8.5%1.440.0%0.13.7%756.8%
2025Q23.8-8.4%1.538.7%0.01.0%-191.8%
2025Q13.84.3%1.643.1%0.512.1%144.9%
2024Q44.510.6%2.147.1%0.715.8%-170.2%
2024Q33.915.0%1.846.4%0.716.6%69.6%
2024Q24.132.4%1.946.2%0.613.6%-17.5%
2024Q13.68.5%1.645.3%0.411.6%-148.9%
2023Q44.169.9%1.845.1%0.49.0%-18.6%
2023Q33.497.9%1.544.6%0.410.6%-286.9%
2023Q23.152.6%1.445.6%-0.1-1.9%-298.8%
2023Q13.4120.4%1.442.0%0.13.6%296.0%
2022Q42.496.8%1.354.7%-0.1-5.1%7.4%
2022Q31.796.2%1.056.3%0.315.3%-634.8%
2022Q22.054.4%1.050.6%1.049.4%-87.9%
2022Q11.5-4.0%0.849.4%1.7111.1%893.9%
2021Q41.2-29.5%0.653.2%0.972.3%-583.6%
2021Q30.9-33.2%0.450.1%1.3151.3%-925.6%
2021Q21.326.4%0.648.4%-1.6-117.2%919.8%
2021Q11.6-48.7%0.954.9%-3.2-201.7%1337.4%
2020Q41.7-54.6%0.954.1%-1.3-74.2%799.0%
2020Q31.3-62.1%0.643.6%-3.1-232.0%720.5%
2020Q21.0-70.2%0.654.5%-0.4-33.5%1196.5%
2020Q13.1-14.4%1.446.2%-0.1-1.7%68.0%
2019Q43.8-85.6%1.643.2%-0.7-17.6%-36.3%
2019Q33.5-94.2%1.544.5%-0.0-1.1%8.6%
2019Q23.5-95.0%1.440.7%-0.4-10.2%10.1%
2019Q13.6-93.9%1.644.0%0.24.7%-59.5%
2018Q426.3-55.3%12.447.3%-0.0-0.2%148.9%
2018Q360.118.8%29.949.7%3.45.6%26.3%
2018Q271.153.3%33.647.2%5.98.3%1.9%
2018Q158.954.7%27.446.5%3.76.2%7.6%
2017Q458.830.5%27.847.3%2.34.0%4.1%
2017Q350.643.7%20.841.1%1.32.7%1.0%
2017Q246.423.7%19.942.8%3.26.9%-0.4%
2017Q138.116.8%16.042.1%2.05.3%-0.5%
2016Q445.120.445.2%0.81.8%-1.6%
2016Q335.213.237.3%0.10.3%5.8%